title: A comparison of two methods of infiltration in breast reduction surgery.
abstract: The superwet technique has been shown in previous studies to dramatically reduce blood loss in breast reduction surgery, compared with standard infiltration. A retrospective chart review of 303 consecutive patients undergoing bilateral breast reduction surgery was undertaken to demonstrate additional differences in complication rate, operative time, or sponge use in the operating room. In this series, 132 consecutive patients received standard infiltration along incision lines (25 cc per breast of 1:100,000 epinephrine), and 171 patients received superwet infiltration with 240 cc per breast of 1:1,000,000 epinephrine. The average operative time was significantly reduced in the superwet group, from 78.5 minutes to 70.7 minutes (p < 0.01 level). The average number of sponges used intraoperatively was also decreased significantly (p < 0.01), from 26 to 20 sponges. Complication rates were equally low in both groups, demonstrating the safety of the superwet technique. In addition to limiting blood loss, the superwet infiltration effectively reduces operative time and sponge use without increasing complications in breast reduction surgery.
authors.affiliation: Division of Plastic Surgery, Sunnybrook and Women's College Health Science Centre, Women's College Campus, University of Toronto, Ontario, Canada.
authors.forename: A D
authors.initials: AD
authors.lastname: Armour
authors.forename: B W
authors.initials: BW
authors.lastname: Rotenberg
authors.forename: M H
authors.initials: MH
authors.lastname: Brown
mesh_terms: D000328:Adult; D000772:Anesthesia, Local; D000779:Anesthetics, Local / Q000008:administration & dosage; D016063:Blood Loss, Surgical / Q000517:prevention & control; D004837:Epinephrine / Q000008:administration & dosage*; D005260:Female; D006488:Hemostasis, Surgical; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage; D016462:Mammaplasty / Q000009:adverse effects / Q000379:methods*; D011183:Postoperative Complications; D012189:Retrospective Studies; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*
chemical_list: D000779:Anesthetics, Local; D014662:Vasoconstrictor Agents; D008012:Lidocaine; D004837:Epinephrine